GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.

Saved in:
Bibliographic Details
Title: GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.
Authors: Mahadevan A; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Vosooghi A; Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Arora JS; School of Medicine, University of California, Irvine, CA 92617, USA., Kumar RS; Department of Medicine, University of Kentucky, Lexington, KY 40506, USA., Singh G; Department of Computer Science, University of California, Davis, CA 95616, USA., Tsai KK; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA., Quandt Z; Division of Endocrinology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.
Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2026 May 19; Vol. 111 (6), pp. 1604-1612.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1945-7197
DOI:10.1210/clinem/dgaf703